CannAmerica Brands Corp. (CNNXF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
CannAmerica Brands Corp. (CNNXF) with AI Score 49/100 (Weak). CannAmerica Brands Corp. operates in the cannabis industry, focusing on brand development and licensing. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 18, 2026CannAmerica Brands Corp. (CNNXF) Healthcare & Pipeline Overview
CannAmerica Brands Corp. is a cannabis brand and licensing company, offering products such as gummies and vape pens across Colorado, Nevada, Oklahoma, and Massachusetts. It focuses on building brand value through marketing and distribution partnerships in the competitive cannabis market, facing evolving regulations and consumer preferences.
Investment Thesis
CannAmerica Brands Corp. presents a speculative investment opportunity within the evolving cannabis market. The company's focus on brand licensing offers a scalable business model, but its negative profit margin of -918.8% indicates significant challenges in achieving profitability. Key value drivers include successful brand development, expansion into new markets, and effective marketing strategies. Growth catalysts include regulatory changes favoring cannabis legalization and increasing consumer acceptance of cannabis products. Potential risks include intense competition, fluctuating cannabis prices, and evolving regulatory landscapes. Investors should closely monitor the company's financial performance, market expansion efforts, and ability to navigate regulatory hurdles. The company's negative beta of -0.60 suggests low correlation with the broader market.
Based on FMP financials and quantitative analysis
Key Highlights
- CannAmerica Brands Corp. operates with a focus on brand licensing within the cannabis industry.
- The company's gross margin stands at 85.0%, indicating strong potential for profitability if operational costs are managed effectively.
- CannAmerica's product line includes cannabis-infused gummies, vape pens, and concentrates, targeting both medical and recreational users.
- The company's market capitalization is $0.00B, reflecting its current stage of development and market perception.
- CannAmerica distributes its products through dispensaries, wholesalers, and distributors in Colorado, Nevada, Oklahoma, and Massachusetts.
Competitors & Peers
Strengths
- Established brand portfolio.
- Distribution network in multiple states.
- Diverse product offerings.
- High gross margin (85.0%).
Weaknesses
- Negative profit margin (-918.8%).
- Limited market capitalization.
- Reliance on third-party distributors.
- Exposure to regulatory risks.
Catalysts
- Upcoming: Potential changes in cannabis regulations at the state or federal level could create new market opportunities.
- Ongoing: Increasing consumer acceptance of cannabis products is driving demand and market growth.
- Ongoing: Expansion of the company's distribution network into new states.
- Upcoming: Launch of new cannabis products or product lines.
- Upcoming: Strategic partnerships with established players in the cannabis industry.
Risks
- Ongoing: Intense competition in the cannabis industry is putting pressure on prices and margins.
- Potential: Fluctuating cannabis prices could impact revenue and profitability.
- Ongoing: Evolving regulatory landscape creates uncertainty and compliance challenges.
- Potential: Potential for increased taxation on cannabis products.
- Potential: Limited access to capital due to the stigma associated with the cannabis industry.
Growth Opportunities
- Expansion into New Markets: CannAmerica has the opportunity to expand its brand licensing operations into additional states as cannabis regulations evolve. The North American cannabis market is projected to reach $47.6 billion by 2029, providing a significant growth runway for companies that can successfully navigate regulatory hurdles and establish strong brand presence in new regions. Successful market entry requires strategic partnerships with local distributors and compliance with state-specific regulations.
- Product Innovation: CannAmerica can drive growth by introducing new and innovative cannabis products to meet evolving consumer preferences. The cannabis edibles market, for example, is expected to grow significantly in the coming years. Developing unique and appealing product formulations, such as novel gummy flavors or specialized vape pen designs, can attract new customers and differentiate CannAmerica from its competitors. This requires investment in research and development and a deep understanding of consumer trends.
- Strategic Partnerships: Forming strategic partnerships with established players in the cannabis industry can accelerate CannAmerica's growth. Collaborating with cultivators, manufacturers, or retailers can provide access to resources, expertise, and distribution channels. For example, partnering with a large-scale cultivator can ensure a consistent supply of high-quality cannabis for CannAmerica's products. These partnerships can also help CannAmerica expand its geographic reach and enter new markets more efficiently.
- Brand Building and Marketing: Investing in brand building and marketing efforts is crucial for CannAmerica to establish a strong brand presence and attract customers. The cannabis market is becoming increasingly competitive, and consumers are more likely to choose brands they recognize and trust. CannAmerica can leverage social media, influencer marketing, and targeted advertising to reach its target audience and build brand awareness. A strong brand can also command premium pricing and increase customer loyalty.
- Focus on Medical Cannabis: While CannAmerica currently offers both medical and recreational cannabis products, focusing on the medical cannabis market could provide a more stable and regulated revenue stream. The medical cannabis market is driven by patients seeking relief from various medical conditions, and demand is less susceptible to economic fluctuations. CannAmerica can develop specialized products tailored to the needs of medical cannabis patients and partner with healthcare providers to promote its products. This requires compliance with strict regulations and a focus on product quality and efficacy.
Opportunities
- Expansion into new geographic markets.
- Development of new cannabis products.
- Strategic partnerships with established players.
- Increasing consumer acceptance of cannabis.
Threats
- Intense competition in the cannabis industry.
- Fluctuating cannabis prices.
- Evolving regulatory landscape.
- Potential for increased taxation.
Competitive Advantages
- Brand recognition in select markets.
- Established distribution network in Colorado, Nevada, Oklahoma, and Massachusetts.
- Proprietary product formulations.
- Licensing agreements provide recurring revenue.
About CNNXF
CannAmerica Brands Corp. was founded with the objective of creating and promoting a portfolio of cannabis brands in the burgeoning medical and recreational cannabis market. The company operates by developing its brands and then licensing them to various distributors, wholesalers, and dispensaries. This strategy allows CannAmerica to focus on brand development and marketing, while leveraging the existing infrastructure of its partners for production and distribution. CannAmerica's product line includes cannabis-infused gummy products, disposable vape pens, distillate droppers, and shatter and wax concentrate products, all marketed under the CannAmerica brand. The company's geographic footprint currently extends to Colorado, Nevada, Oklahoma, and Massachusetts, with potential for further expansion as regulations evolve and new markets open up. CannAmerica aims to establish a strong brand presence and capture market share in the competitive cannabis industry through strategic partnerships and product innovation. The company is headquartered in Vancouver, Canada.
What They Do
- Owns a portfolio of cannabis brands.
- Licenses its brands to distributors and dispensaries.
- Markets and promotes its brands to consumers.
- Offers cannabis-infused gummy products.
- Provides disposable vape pens.
- Sells distillate droppers.
- Offers shatter and wax concentrate products.
Business Model
- Develops and owns cannabis brands.
- Licenses brands to third-party manufacturers and distributors.
- Generates revenue through licensing fees and royalties.
- Focuses on marketing and brand promotion.
Industry Context
CannAmerica Brands Corp. operates in the rapidly growing cannabis industry, which is characterized by evolving regulations, increasing consumer demand, and intense competition. The market includes both medical and recreational cannabis products, with various companies vying for market share. CannAmerica's focus on brand licensing positions it within a segment that requires strong marketing and distribution partnerships. The industry is subject to changing legal frameworks and consumer preferences, requiring companies to adapt quickly. Competitors range from large, established cannabis companies to smaller, niche brands.
Key Customers
- Cannabis dispensaries.
- Wholesalers and distributors of cannabis products.
- Medical cannabis patients.
- Recreational cannabis users.
Financials
Chart & Info
CannAmerica Brands Corp. (CNNXF) stock price: Price data unavailable
Latest News
-
Stocks That Hit 52-Week Lows On Tuesday
· Oct 15, 2019
-
Stocks That Hit 52-Week Lows On Wednesday
· Oct 2, 2019
-
Stocks That Hit 52-Week Lows On Tuesday
· Oct 1, 2019
-
Stocks That Hit 52-Week Lows On Monday
· Sep 30, 2019
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CNNXF.
Price Targets
Wall Street price target analysis for CNNXF.
MoonshotScore
What does this score mean?
The MoonshotScore rates CNNXF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Diana Anglin
CEO
Diana Anglin serves as the CEO of CannAmerica Brands Corp. Her background includes experience in business development, marketing, and operations within the cannabis industry. She has been involved in various aspects of the cannabis sector, from cultivation and processing to retail and brand management. Anglin's expertise lies in building and scaling cannabis businesses, navigating regulatory complexities, and developing effective marketing strategies.
Track Record: Under Diana Anglin's leadership, CannAmerica Brands Corp. has focused on expanding its brand portfolio and distribution network. Key milestones include establishing partnerships with distributors in multiple states and launching new cannabis products. Anglin has also overseen the company's efforts to comply with evolving cannabis regulations and adapt to changing market conditions. Her strategic decisions have aimed to position CannAmerica for growth in the competitive cannabis industry.
CNNXF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that CannAmerica Brands Corp. may not meet the minimum financial or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory scrutiny as those listed on major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries higher risks due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure.
- Low trading volume and liquidity.
- Potential for price manipulation.
- Higher risk of fraud or mismanagement.
- Limited regulatory oversight.
- Verify the availability and accuracy of financial statements.
- Assess the company's management team and their track record.
- Research the company's business model and competitive landscape.
- Evaluate the company's compliance with regulatory requirements.
- Monitor trading volume and price volatility.
- Consult with a financial advisor.
- Understand the risks associated with OTC investments.
- Established brand portfolio.
- Distribution network in multiple states.
- High gross margin (85.0%).
- CEO with industry experience.
- Operation in regulated cannabis markets.
CannAmerica Brands Corp. Stock: Key Questions Answered
What does CannAmerica Brands Corp. do?
CannAmerica Brands Corp. operates as a brand and licensing company within the cannabis industry. It develops and owns a portfolio of cannabis brands, which it then licenses to third-party manufacturers, distributors, and dispensaries. The company generates revenue through licensing fees and royalties, focusing on marketing and brand promotion to drive demand for its products. CannAmerica's product line includes cannabis-infused gummies, vape pens, and concentrates, targeting both medical and recreational users in states where cannabis is legal.
What do analysts say about CNNXF stock?
There is currently no available analyst coverage for CNNXF stock. Given the company's OTC listing and limited market capitalization, it is not widely followed by analysts. Investors should conduct their own due diligence and rely on publicly available information to assess the company's prospects. Key valuation metrics to consider include revenue growth, gross margin, and profitability. Growth considerations include market expansion opportunities and the company's ability to navigate regulatory challenges.
What are the main risks for CNNXF?
The main risks for CannAmerica Brands Corp. include intense competition in the cannabis industry, fluctuating cannabis prices, and the evolving regulatory landscape. The company's small size and limited resources make it vulnerable to larger, better-funded competitors. Changes in cannabis regulations at the state or federal level could impact the company's ability to operate and expand. Additionally, the company's reliance on third-party distributors exposes it to potential disruptions in the supply chain.
What are the key factors to evaluate for CNNXF?
CannAmerica Brands Corp. (CNNXF) currently holds an AI score of 49/100, indicating low score. Key strength: Established brand portfolio.. Primary risk to monitor: Ongoing: Intense competition in the cannabis industry is putting pressure on prices and margins.. This is not financial advice.
How frequently does CNNXF data refresh on this page?
CNNXF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven CNNXF's recent stock price performance?
Recent price movement in CannAmerica Brands Corp. (CNNXF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Established brand portfolio.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider CNNXF overvalued or undervalued right now?
Determining whether CannAmerica Brands Corp. (CNNXF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying CNNXF?
Before investing in CannAmerica Brands Corp. (CNNXF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on publicly available sources and may be subject to change.
- Financial data may be limited due to the company's OTC listing.